COSMO Pharmaceuticals (Switzerland) Market Value

COPN Stock  CHF 63.70  2.50  4.08%   
COSMO Pharmaceuticals' market value is the price at which a share of COSMO Pharmaceuticals trades on a public exchange. It measures the collective expectations of COSMO Pharmaceuticals SA investors about its performance. COSMO Pharmaceuticals is selling for under 63.70 as of the 28th of December 2024; that is 4.08% up since the beginning of the trading day. The stock's lowest day price was 61.5.
With this module, you can estimate the performance of a buy and hold strategy of COSMO Pharmaceuticals SA and determine expected loss or profit from investing in COSMO Pharmaceuticals over a given investment horizon. Check out COSMO Pharmaceuticals Correlation, COSMO Pharmaceuticals Volatility and COSMO Pharmaceuticals Alpha and Beta module to complement your research on COSMO Pharmaceuticals.
Symbol

Please note, there is a significant difference between COSMO Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if COSMO Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, COSMO Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

COSMO Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to COSMO Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of COSMO Pharmaceuticals.
0.00
11/28/2024
No Change 0.00  0.0 
In 31 days
12/28/2024
0.00
If you would invest  0.00  in COSMO Pharmaceuticals on November 28, 2024 and sell it all today you would earn a total of 0.00 from holding COSMO Pharmaceuticals SA or generate 0.0% return on investment in COSMO Pharmaceuticals over 30 days. COSMO Pharmaceuticals is related to or competes with Basilea Pharmaceutica, Newron Pharmaceuticals, Santhera Pharmaceuticals, and Evolva Holding. Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, develops, manufactures, and distributes products for gas... More

COSMO Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure COSMO Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess COSMO Pharmaceuticals SA upside and downside potential and time the market with a certain degree of confidence.

COSMO Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for COSMO Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as COSMO Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use COSMO Pharmaceuticals historical prices to predict the future COSMO Pharmaceuticals' volatility.
Hype
Prediction
LowEstimatedHigh
62.5163.7064.89
Details
Intrinsic
Valuation
LowRealHigh
57.3365.5066.69
Details

COSMO Pharmaceuticals Backtested Returns

COSMO Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.22, which signifies that the company had a -0.22% return per unit of volatility over the last 3 months. COSMO Pharmaceuticals SA exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm COSMO Pharmaceuticals' risk adjusted performance of (0.18), and Mean Deviation of 0.8788 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0554, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning COSMO Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, COSMO Pharmaceuticals is likely to outperform the market. At this point, COSMO Pharmaceuticals has a negative expected return of -0.26%. Please make sure to confirm COSMO Pharmaceuticals' maximum drawdown, potential upside, kurtosis, as well as the relationship between the value at risk and skewness , to decide if COSMO Pharmaceuticals performance from the past will be repeated at future time.

Auto-correlation

    
  -0.74  

Almost perfect reverse predictability

COSMO Pharmaceuticals SA has almost perfect reverse predictability. Overlapping area represents the amount of predictability between COSMO Pharmaceuticals time series from 28th of November 2024 to 13th of December 2024 and 13th of December 2024 to 28th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of COSMO Pharmaceuticals price movement. The serial correlation of -0.74 indicates that around 74.0% of current COSMO Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient-0.74
Spearman Rank Test-0.33
Residual Average0.0
Price Variance2.88

COSMO Pharmaceuticals lagged returns against current returns

Autocorrelation, which is COSMO Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting COSMO Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of COSMO Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that COSMO Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

COSMO Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If COSMO Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if COSMO Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in COSMO Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

COSMO Pharmaceuticals Lagged Returns

When evaluating COSMO Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of COSMO Pharmaceuticals stock have on its future price. COSMO Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, COSMO Pharmaceuticals autocorrelation shows the relationship between COSMO Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in COSMO Pharmaceuticals SA.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for COSMO Stock Analysis

When running COSMO Pharmaceuticals' price analysis, check to measure COSMO Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSMO Pharmaceuticals is operating at the current time. Most of COSMO Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of COSMO Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSMO Pharmaceuticals' price. Additionally, you may evaluate how the addition of COSMO Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.